Your browser doesn't support javascript.
loading
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
Boddicker, Rebecca L; Kip, N Sertac; Xing, Xiaoming; Zeng, Yu; Yang, Zhi-Zhang; Lee, Jeong-Heon; Almada, Luciana L; Elsawa, Sherine F; Knudson, Ryan A; Law, Mark E; Ketterling, Rhett P; Cunningham, Julie M; Wu, Yanhong; Maurer, Matthew J; O'Byrne, Megan M; Cerhan, James R; Slager, Susan L; Link, Brian K; Porcher, Julie C; Grote, Deanna M; Jelinek, Diane F; Dogan, Ahmet; Ansell, Stephen M; Fernandez-Zapico, Martin E; Feldman, Andrew L.
Afiliação
  • Boddicker RL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Kip NS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Xing X; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pathology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China;
  • Zeng Y; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; Department of Pathology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China;
  • Yang ZZ; Division of Hematology.
  • Lee JH; Epigenomics Translational Program, Center for Individualized Medicine.
  • Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, and.
  • Elsawa SF; Schulze Center for Novel Therapeutics, Division of Oncology Research, and.
  • Knudson RA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Law ME; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Wu Y; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Maurer MJ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN;
  • O'Byrne MM; Department of Health Sciences Research, Mayo Clinic, Rochester, MN;
  • Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN;
  • Slager SL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN;
  • Link BK; Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA; and.
  • Porcher JC; Division of Hematology.
  • Grote DM; Division of Hematology.
  • Jelinek DF; Division of Hematology, Department of Immunology, Mayo Clinic, Rochester, MN.
  • Dogan A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
  • Ansell SM; Division of Hematology.
  • Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, and.
  • Feldman AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
Blood ; 125(20): 3118-27, 2015 May 14.
Article em En | MEDLINE | ID: mdl-25833963
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / NF-kappa B / Antígeno Ki-1 / Fatores Reguladores de Interferon Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / NF-kappa B / Antígeno Ki-1 / Fatores Reguladores de Interferon Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2015 Tipo de documento: Article